INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Piramal Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543635	ISIN Demat INE0DK501011	Book Value 58.28	NSE Symbol PPLPHARMA	Dividend Yield (%) 0.08	Market Cap (₹ Cr.) 23,195.38	P/E 32.86	EPS 5.31	Face Value 10

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	5,285.71	4,390.11	3,443.22	3,340.42	2,938.81
Sale of Products	4,913.78	3,980.39	2,968.57	2,915.88	2,477.52
Sale of Services	447.77	557.27	436.61	302.94	422.23
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	-75.84	-147.55	38.04	121.60	39.06
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	5,285.71	4,390.11	3,443.22	3,340.42	2,938.81
Other Income	207.35	202.06	341.07	224.79	197.97
Total Revenue	5,493.06	4,592.17	3,784.29	3,565.21	3,136.78
Changes in Inventories	-84.57	-61.62	53.31	-32.66	57.86
Cost of Material Consumed	1,596.93	1,545.55	1,166.48	1,083.93	986.70
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	733.60	624.91	548.69	510.24	183.21
Employee Benefits	736.19	613.93	548.50	448.03	395.15
Total Other Expenses	1,263.12	1,049.42	1,028.71	855.60	696.96
Manufacturing / Operating Expenses	415.97	364.46	367.23	383.66	320.82
Administrative and Selling Expenses	746.69	620.04	485.63	427.82	258.75
Other Expenses	100.46	64.92	175.85	44.12	117.39
Finance Costs	114.56	107.10	115.87	57.29	4.71
Depreciation and Amortization	222.09	205.26	192.08	165.37	143.64
Total Expenses	4,581.92	4,084.55	3,653.64	3,087.80	2,468.23
Profit Before Exceptional Items and Tax	911.14	507.62	130.65	477.41	668.55
Exceptional Items Before Tax	0.00	0.00	-6.96	-15.08	18.23
Profit Before Extraordinary Items and Tax	911.14	507.62	123.69	462.33	686.78
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	911.14	507.62	123.69	462.33	686.78
Taxation	219.74	116.40	54.19	94.79	115.28
Current Tax	199.44	112.48	38.77	110.82	104.98
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	20.30	3.92	15.42	-16.03	10.30
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	691.40	391.22	69.50	367.54	571.50
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	691.40	391.22	69.50	367.54	571.50
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	691.40	391.22	69.50	367.54	571.50
Earning Per Share - Basic	5.22	3.05	0.57	3.12	9.11
Earning Per Share - Diluted	5.20	3.05	0.57	3.12	9.11
Operation Profit before Depreciation	1,247.79	819.98	438.60	700.07	816.90
Operating Profit after Depreciation	1,025.70	614.72	246.52	534.70	673.26
Dividend Per Share	0.14	0.11	0.00	0.00	0.00
Dividend Percentage	1.40	1.10	0.00	0.00	0.00
Equity Dividend	18.54	14.70	0.00	0.00	0.00
Weighted Average Shares - Basic	132.44	132.29	121.27	117.89	62.76
Weighted Average Shares - Diluted	132.44	132.29	121.27	117.89	62.76